AMICUS THERAPEUTICS EUROPE LIMITED
ItalyAll drugs from this manufacturer
-
It is used for the long-term treatment of Fabry disease in adults and adolescents (from 12 years of age and older) who have certain genetic mutations. It works by stabilizing the enzyme naturally produced by the body to reduce the accumulation of a fatty substance (GL-3) in the organs.
Dosage form: capsules, hard gelatin
Active substance Dosage migalastat - ATC: A16AX14
-
Opfolda is used for the treatment of late-onset Pompe disease in adults. It is always used in conjunction with another medicine called cipaglucosidase alfa.
Dosage form: capsules, hard gelatin
Active substance Dosage miglustat - ATC: A16AX06
-
It is used for the treatment of late-onset Pompe disease in adults. It works by helping to break down the glycogen that accumulates in the muscles, allowing them to function correctly.
Dosage form: powder for concentrate for infusion solution
Active substance Dosage cipaglucosidase alfa - ATC: A16AB23